New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders
AbstractFollowing the discovery of the endocannabinoid system and its potential as a therapeutic target for various pathological conditions, growing interest led researchers to investigate the role of cannabis and its derivatives for medical purposes. The compounds Δ9-tetrahydrocannabinol and cannabidiol are the most abundant phytocannabinoids found in cannabis extracts, as well as the most studied. The present review aims to provide an overview of the current evidence for their beneficial effects in treating psychiatric disorders, including schizophrenia, anxiety, and depression. Nevertheless, further investigations are required to clarify many pending issues, especially those relative to the assessment of benefits and risks when using cannabis for therapeutic purposes, thereby also helping national and federal jurisdictions to remain updated. View Full-Text
Share & Cite This Article
Scherma, M.; Masia, P.; Deidda, M.; Fratta, W.; Tanda, G.; Fadda, P. New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders. Medicines 2018, 5, 107.
Scherma M, Masia P, Deidda M, Fratta W, Tanda G, Fadda P. New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders. Medicines. 2018; 5(4):107.Chicago/Turabian Style
Scherma, Maria; Masia, Paolo; Deidda, Matteo; Fratta, Walter; Tanda, Gianluigi; Fadda, Paola. 2018. "New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders." Medicines 5, no. 4: 107.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.